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Enlarging the Stokes Shift by Weakening the 𝝅-Conjugation
of Cyanines for High Signal-to-Noise Ratiometric Imaging
Yongkang Yue, Tingting Zhao, Zhou Xu, Weijie Chi, Xiaojun Chai, Jiahong Ai,
Jiawei Zhang, Fangjun Huo, Robert M. Strongin, and Caixia Yin*
analyses.[1,2] However, the performance of
many common organic ﬂuorescent dyes is
restricted by their low signal-to-noise ratio (SNR). This is particularly problematic in the context of in vivo imaging
applications.[3–5] Not surprisingly, therefore, in recent years scientists have worked
to enhance the inherent signal intensity, reduce the noise or optimize both parameters
to improve the SNR.[6]
Molecular features that could improve
the SNR include 1) increasing the ﬂuorescence emission wavelength; 2) enhancing
the Stokes shift; and 3) targeting the ﬂuorescence or chemiluminescence.[7] The beneﬁts of the ﬁrst approach is that ﬂuorescence
emission in the NIR region would not only
avoid the noise caused by tissue autoﬂuorescence, but also allow for improved signal
readout as the result of better tissue penetration and lower light scattering.[8] Since
they were reported by Williams in 1856,
cyanine dyes, especially heptamethine cyanines (Cy-7), have been used extensively
as NIR photosensitizers and ﬂuorescent
probes.[9–12] The second strategy for increasing the SNR, namely
improving the Stokes shift, is particularly germane to Cy-7 dyes,
which typically feature narrow Stokes shifts, generally less than
25 nm (Figures S1 and S2, Supporting Information). This small
shift results in so-called crosstalk between the excitation and
emission bands and results in a diminished SNR relative to what

The signal-to-noise ratio (SNR) is one of the key features of a ﬂuorescent
probe and one that often deﬁnes its potential utility for in vivo labeling and
analyte detection applications. Here, it is reported that introducing a pyridine
group into traditional cyanine-7 dyes in an asymmetric manner provides a
series of tunable NIR ﬂuorescent dyes (Cy-Mu-7) characterized by enhanced
Stokes shifts (≈230 nm) compared to the parent cyanine 7 dye (<25 nm). The
observed Stokes shift increase is ascribed to symmetry breaking of the
Cy-Mu-7 core and a reduction in the extent of conjugation. The ﬂuorescence
signals of the Cy-Mu-7 dyes are enhanced upon conﬁnement within the
hydrophobic cavity of albumin or via spontaneous encapsulation within
micelles in aqueous media. Utilizing the Cy-Mu-7, ultra-fast in vivo kidney
labeling in mice is realized, and it is found that the liver injury will aggravate
the burden of kidney by monitoring the ﬂuorescence intensity ratio of kidney
to liver. In addition, Cy-Mu-7 could be used as eﬃcient chemiluminescence
resonance energy transfer acceptor for the reaction between H2 O2 and
bisoxalate. The potential utility of Cy-Mu-7 is illustrated via direct monitoring
ﬂuctuations in endogenous H2 O2 levels in a mouse model to mimic
emergency room trauma.

1. Introduction
Organic ﬂuorescent dyes are among the most widely used labeling tools. They have enabled unprecedented insights into
both cellular and in vivo processes and are appealing because
of the relatively noninvasive nature of emission-based optical
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would otherwise be expected.[10,13,14] In fact, in the case of several
recently reported cyanine-based NIR-II dyes, their narrow Stokes
shifts was recognized as being one of the key parameters that
limited their utility in bio-imaging applications.[11] The third approach to improving the SNR has been widely exploited to construct bio-labeling tools. However, further beneﬁts might be expected if the Stokes shift could be enhanced, especially in the case
of cyanine-based NIR-II dyes. Focused on the rational molecular
design of satisfactory in vivo imaging dyes, we hope to improve
the restrictions such as narrow Stokes shifts and always-ON ﬂuorescence signals of Cy-7 while preserve their NIR ﬂuorescence
emission feature. We found that asymmetrical introduction of a
pyridine group to the symmetric Cy-7 dyes would reduce the conjugate eﬀect and lead to a >200 nm increase in the Stokes shift.
For convenience, we refer to these new derivatives as Cy-Mu-7
dyes.
The Cy-Mu-7 dyes bind spontaneously to the low-polarity hydrophobic cavity of albumin (domain IIIb) when mixed in aqueous media. This binding is likely driven by the hydrophobic
eﬀect, restricts the rotation of the pyridine moiety, and enhances the ﬂuorescence signal (6.4-fold enhancement comparing with the Cy-7). Increases in emission intensity were also
seen when the Cy-Mu-7 dyes were encapsulated in micelles
such as Pluronic F-127, a commercial copolymer surfactant. CyMu-7 was found to bind to serum albumin after IV injection.
Within 1 min post-injection, the kidneys were found to light
up (luminesce) and with a high SNR compared with ICG or
indole-Cy-7. This allowed Cy-Mu-7 to be used to image in vivo
in nephrotoxic drug-induced albuminuria, one of the biomarkers of acute kidney injury (AKI), at an early stage of AKI.[15,16]
Cy-Mu-7 was also encapsulated in Pluronic F-127 along with
bis[3,4,6-trichloro-2-(pentyl-oxycarbonyl)phenyl]oxalate (CPPO),
a species that produces chemiluminescence in the presence
of hydrogen peroxide (H2 O2 ). The nanoprobe prepared in this
way allows visualization of the transient production and ﬂuctuation of endogenous H2 O2 as the result of chemiluminescence resonance energy transfer (CRET) between the CPPOderived 1,2-dioxetanedione and the Cy-Mu-7 dye.[17,18] This system could be applied to a murine model for emergency room
trauma.

2. Results and Discussion
2.1. Synthesis of the Asymmetrical Cy-Mu-7 Dyes
Detailed synthetic protocols and characterizations are presented
in Supporting Information. Typically, the N-methyl-indole derivative (Cy-Mu-7) could be readily synthesized via two steps asymmetrical insertion of the N-methyl-indole moiety and pyridine
moiety successively. For the N-propionyloxy-indole derivative (CyMu-7-COOH), the presence of hyamine could catalyze ester condensation reaction in EtOH with the formation of an N-propionic
ether derivative (Cy-Mu-7-ester). So, we used acetonitrile and
methylbenzene as the solvents in the two steps Cy-Mu-7-COOH
synthesis, respectively. Based on a similar synthetic protocol, the
benzindole-modiﬁed derivative could also be obtained (Cy-Mu-7benzene).
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2.2. Spectral Properties of Cy-Mu-7 Dyes
Cy-Mu-7 features typical absorption band centered at 570 nm in
PBS with a molar extinction coeﬃcient (𝜖) of 11 760 m−1 cm−1
(Figure 1 and Table 1). Compared with the traditional symmetric
Cy-7 (775 nm, 𝜖 = 125 510 m−1 cm−1 ), the maximum absorption
peak of Cy-Mu-7 was reduced by ≈200 nm. Even though with distinct absorption bands, Cy-Mu-7 and Cy-7 displayed similar ﬂuorescence emission spectra centered at ≈800 nm in PBS. These
spectral results indicated that Cy-Mu-7 reserved the NIR ﬂuorescence emission of heptamethine cyanine while featured >200 nm
Stokes shift.
Density functional theory (DFT) and time-dependent DFT
(TD-DFT) were then employed to understand the structural and
electronic properties of Cy-7 and Cy-Mu-7 in the Gaussian 16 A
code.[19] As shown in Figure 2A, both of the highest occupied
molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO) of Cy-7 and Cy-Mu-7 are located in the whole
molecules. Compared with the highly symmetrical electron density distributions of Cy-7 during the HOMO → LUMO transition,
the excitation process of Cy-Mu-7 induced distinct electron density changes from the indole moiety to the pyridine moiety. The
calculated centroid distances between the HOMO and LUMO of
Cy-7 and Cy-Mu-7 were 0.37 and 5.40 Å, respectively, which indicated a larger Stokes shift of Cy-Mu-7 over Cy-7.[20] The HOMO
and LUMO levels of Cy-7 and Cy-Mu-7 also reﬂected the spectral
diﬀerences. The asymmetrical introduction of a pyridine moiety elevated the LUMO energy level of the cyanine signiﬁcantly
(ΔELUMO = 0.366 eV). As a result, Cy-Mu-7 (3.702 eV) exhibits a
larger energy gap than Cy-7 (3.507 eV), which leads to a signiﬁcantly hypochromatic shift of the maximum absorption peak of
Cy-Mu-7 compared to Cy-7. The oscillator strength (f), which was
positively correlated to the 𝜖 of the dyes, of Cy-Mu-7 (f = 1.9) was
also reduced by ≈26% compared to Cy-7 (f = 2.4).[21] All of these
computational results were in good agreement with the experimental spectral data.
The changes in maximum absorption peak and oscillator
strength in Cy-Mu-7 can be rationalized by 𝜋 electron distribution, which was characterized by Localized Orbital Locator (LOL𝜋).[22,23] We showed that the LOL-𝜋 of Cy-Mu-7 exhibits a narrower distribution compared with Cy-7, which results in a reduction of the conjugate eﬀect (Figure 2B). In other words, the
hypochromatic shift of the maximum absorption peak and reduction of oscillator strength mainly stems from the weak conjugate
eﬀect of Cy-Mu-7. From the point of view of molecular structure,
the symmetry breaking of Cy-Mu-7 caused the reduction of the
conjugate eﬀect.
The molecular design strategy to construct heptamethine cyanine dyes with large Stokes shift could be veriﬁed by the spectral
properties of Cy-Mu-7 derivatives. All of these dyes featured similar UV–vis absorption and NIR ﬂuorescence emission properties
in PBS (Figure S3, Supporting Information and Table 1). The corresponding Stokes shifts varied from 225 to 254 nm. Cy-Mu-7COOH and Cy-Mu-7-ester supported the feasibility of these dyes
for diverse biological applications upon further modiﬁcation.
Since the NIR ﬂuorescence dyes are preferred in vivo imaging
tools, we evaluated the spectral responses of Cy-Mu-7 dyes toward
albumin, the most abundant protein in animal plasma, to support the potential in vivo imaging applications. HSA as a typical
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Figure 1. A) Structures of traditional Cy-7 dyes and the asymmetrical Cy-Mu-7 dyes and B) their representative photophysical properties in PBS.

Table 1. Photophysical properties of Cy-Mu-7 dyes, Indole-Cy-7, and ICG with or without HSA. The absolute ﬂuorescence quantum yields of the dyes
were determined in PBS.
Dyes

Cy-Mu-7
Cy-Mu-7-COOH
Cy-Mu-7-ester
Cy-Mu-7-benzene
Indole-Cy-7
ICG

Abs.
[nm]

Fl.
[nm]

𝜖
[105 m−1 cm−1 ]

Φ
[%]

Stokes shift
[nm]

–

570

800

0.1176

1.26

148.176

230

+ HSA

600

755

0.4869

2.59

1261.071

155

–

574

800

0.1371

0.62

85.002

226

+ HSA

580

775

0.1251

0.99

123.849

195

–

565

790

0.2074

0.33

68.442

225

+ HSA

573

736

0.2331

1.68

391.608

163

–

550

804

0.1471

0.56

82.376

254

+ HSA

610

775

0.2695

3.94

1061.83

165

–

775

803

1.2551

2.77

3476.627

28

+ HSA

797

815

1.2651

4.6

5819.46

18

–

777

804

0.6706

1.53

1026.018

27

+ HSA

796

816

1.5629

2.94

4594.926

20

albumin was primarily evaluated in the following experiments.
All of these Cy-Mu-7 dyes could bind HSA with similar spectral
changes. Typically, the presence of HSA induced bathochromic
shift of the absorption wavelength and hypochromatic shift of the
ﬂuorescence emission wavelength in PBS. At the same time, the
increased 𝜖 and ﬂuorescence quantum yield (Φ) after HSA binding brought signiﬁcant ﬂuorescence brightness enhancement of
the dyes containing PBS solution. For the N-methyl-indole CyMu-7, HSA binding induced 11-fold ﬂuorescence intensity enhancement at 755 nm (Figure 3B). The corresponding Stokes
shifts changed from 230 nm (Cy-Mu-7) to 155 nm (Cy-Mu-7HSA). The ﬂuorescence intensity of HSA added Cy-Mu-7 system was HSA concentration-dependent with a Ka (association
constant) of 1.9 × 105 m−1 (Figure 3C and Figure S4, Supporting Information). The binding molar ratio of Cy-Mu-7 and HSA
was measured to be 1: 1 based on the equimolar method (Figure 3D).[24] Besides, RSA and BSA could also bind to Cy-Mu-7
with similar ﬂuorescence responses in PBS, the corresponding
ﬂuorescence intensities were weaker compared with the HSA
addition system under the same condition (Figure 3E). In the
case of Cy-7, however, HSA binding induced negligible ﬂuorescence brightness changes in aqueous solution. The potential in
vivo imaging properties improvement could be evaluated by cov-
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Brightness
𝜖Φ[M−1 cm−1 ]

ering muscle tissue upon the solutions. Figure S5 (Supporting
Information) displays the ﬂuorescence imaging results of 10 μm
Cy-Mu-7 and Cy-7 with/without HSA upon 0.5 mm pork covering. 6.4-fold ﬂuorescence signal enhancement was presented
for the Cy-Mu-7 over Cy-7 case. Thus, the new Cy-Mu-7 dyes are
promising as activable NIR ﬂuorescence probes for albumin related physiological processes and diseases diagnosis.
The binding mode of Cy-Mu-7 and HSA was then analyzed
by SDS-PAGE gel and no ﬂuorescence signal appeared in the
HSA band after electrophoresis which meant the non-covalent
binding mode (Figure S6, Supporting Information). We then
performed competitive inhibition experiments upon the addition of the reported HSA non-covalent binding compounds with
diﬀerent binding domains to determine its non-covalent binding site. As shown in Figure 3F (detailed in Figure S7, Supporting Information), upon pre-incubation of compounds including ibuprofen, warfarin, APAP, aspirin, NEM, sulfasalazine,
camptothecin, and clopidogrel with HSA, respectively, only sulfasalazine exhibited the further combination of Cy-Mu-7. Sulfasalazine with high concentration was reported to bind to HSA
with a molar ratio of 3:1.[25] The three binding sites were Sudlowsite I, domain IIIb and the interface between domains IIIa and
IIIb of HSA with increasing dissociation constants (Figure S8,

2205080 (3 of 11)

© 2022 The Authors. Advanced Science published by Wiley-VCH GmbH

21983844, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/advs.202205080 by Portland State University Mill, Wiley Online Library on [13/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

www.advancedsciencenews.com

www.advancedscience.com
for the notion that Cy-Mu-7 warrants consideration as a probe for
albumin-related in vivo imaging.

2.3. In Vivo and In Vitro Diagnostic Imaging by Cy-Mu-7

Figure 2. Computational results of Cy-7 and Cy-Mu-7 in water. A) The calculated distributions, energy levels (EHOMO and ELUMO ) of HOMO and
LUMO, energy gaps (ΔE, ΔE = ELUMO – EHOMO ), maximum absorption
wavelength (𝜆abs ), and oscillator strength (f) of Cy-7 and Cy-Mu-7. B) Isosurface map of LOL-𝜋 of Cy-7 and Cy-Mu-7 with iso-value of 0.4 at M062X/6-31G(d) level.

Supporting Information). However, considering the high aﬃnity of warfarin in the center of Sudlow-site I, domain IIIb might
be the preferred binding site for Cy-Mu-7.[26] Supported by these
results, molecular docking calculations were conducted to verify
the binding mode of Cy-Mu-7 or Cy-Mu-7-ester with the ligandremoved crystal structure of HSA (PDB ID: 6R7S).[25,27] 23 and
142 distinct conformational clusters were found for Cy-Mu-7 and
Cy-Mu-7-ester based docking out of 2000 runs, respectively. Both
of them presented domain IIIb as the energetically favorable
binding domain which is overlapped exactly with the reported
binding site of sulfasalazine (Figure S9, Supporting Information). Typically, the hydrophobic alkene moiety of Cy-Mu-7 intercalated with the strong hydrophobic area of domain IIIb formed
by Phe-507, Phe-509, and Phe-551 (Figure S9A, Supporting Information). The pyridine moiety was embedded in the cavity of the
domain while the N-methyl-indole moiety as the rivet was stuck
over the domain which permitted the further modiﬁcation of CyMu-7. In the following solvents-dependent spectroscopic studies,
we noticed that the lowered polarity would induce bathochromicshift of the absorption wavelength of Cy-Mu-7 and enhanced
viscosity would permit the blue-shift of the ﬂuorescence signal
(Figure S10, Supporting Information). Thus, the low-polarity hydrophobic environment which further restricted the motion of
pyridine moiety induced the ﬂuorescence enhancement. In addition, Cy-Mu-7 did not respond to biological amino acids and the
activated ﬂuorescence system of Cy-Mu-7-HSA was inert in aqueous solution even in the presence of reactive oxygen species (Figure S11, Supporting Information). These results provide support
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In order to perform biological imaging experiments, CCK-8 assay was then used to evaluate the cytotoxicity of Cy-Mu-7 in HeLa
cells. After incubation for 12 h, 5 μm Cy-Mu-7 did not induce
signiﬁcant cell death (Figure S12, Supporting Information). So,
5 μm Cy-Mu-7 was used to incubate cells in the following cell
imaging experiments. Compared with the cells incubated with
Cy-Mu-7 containing PBS directly, HSA loaded cells displayed signiﬁcant ﬂuorescence enhancement in the NIR channel (Figure
S13, Supporting Information). The results demonstrated that CyMu-7 was membrane permeable and could bind to HSA in situ
in living HeLa cells with turn-on ﬂuorescence signal.
Exogenous substances are generally cleared through the synergistic eﬀect of liver metabolism and renal excretion after IV injection into the blood circulation system.[28] The glomerular ﬁltration membrane of the kidney is constituted by negatively charged
layers to prevent the ﬁltration of natural proteins but permit the
clearance of positively charged molecules owing to electrostatic
interactions.[29,30] Thus, we assumed that the positively charged
Cy-Mu-7 might label kidney eﬃciently after binding to albumin
spontaneously with NIR ﬂuorescence emission (Figure 4A). The
Cy5.5 imaging channel with the excitation at 605 nm was used in
the following in vivo imaging experiments. As shown in Figure
S14 (Supporting Information), IV injection of 160 μm Cy-Mu-7 in
PBS or PBS solution containing 160 μm Cy-Mu-7 and 10 mg mL−1
HSA induced distinct ﬂuorescence signal enhancement in the
kidneys of mice which demonstrated our assumption that CyMu-7 could be used for kidney labeling in vivo. Consistent with
the ﬂuorescence spectral data, Cy-Mu-7-HSA featured stronger
ﬂuorescence signal in vivo. So, in the following in vivo experiments, pre-bound Cy-Mu-7-HSA was used to ensure higher signal to noise ratio. Besides, Cy-Mu-7-ester and Cy-Mu-7-COOH
could also label kidney instantaneously after IV injection (Figure
S15, Supporting Information). In a following time-dependent in
vivo imaging experiment, we noticed that the kidneys of mice
could be lightened within 1 min with ﬁvefold ﬂuorescence signal
enhancement after IV injection (Figure 4B,C) which is as faster
as the present reported renal-clearable ﬂuorescence dyes.[31] For
traditional Cy-7 dyes, however, after IV injection of Indole-Cy-7
or ICG at the same dose as Cy-Mu-7, the mice showed systemic
ﬂuorescence enhancement, especially in the liver, which masked
the potential renal labeling of these dyes (Figure S16, Supporting Information). The results further highlighted the important
structural modiﬁcation of Cy-Mu-7 dyes for better in vivo imaging applications.
The kidneys excrete metabolic wastes produced in the body
with the urine being subject to glomerular blood ﬁltration and
renal tubular secretion. In the early stage of AKI diseases such as
acute glomerular inﬂammation and acute interstitial nephritis,
the urine protein concentration increases signiﬁcantly, resulting
in albuminuria.[15,32] Cy-Mu-7 dyes displayed weak ﬂuorescence
in aqueous solution while strong NIR ﬂuorescence emission after binding to albumin. So, we considered it like that albuminuria in an AKI model might lead to the bladder lightening upon
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Figure 3. Optical properties of Cy-Mu-7 in the presence of human serum albumin (HSA). A) UV–vis absorption changes upon addition of 1 mg mL−1 HSA
into 10 μm Cy-Mu-7 containing PBS system. B) The corresponding ﬂuorescence spectra changes of (A). C) HSA concentration dependent ﬂuorescence
intensity changes of 10 μm Cy-Mu-7 containing PBS system. D) Fluorescence intensity (I = 755 nm) analysis of the mixture containing Cy-Mu-7 and
HSA with diﬀerent ratios, the overall concentration of the mixture was 20 μm. E) Fluorescence responses of 10 μm Cy-Mu-7 toward 1 mg mL−1 HSA,
rat serum albumin (RSA) or bovine serum albumin (BSA). F) Fluorescence intensity changes of 10 μm Cy-Mu-7 in the presence of 1 mg mL−1 HSA preincubated with 400 μm various compounds including ibuprofen, warfarin, acetaminophen (APAP), aspirin, sulfasalazine, camptothecin, clopidogrel, and
N-ethylmaleimide (NEM), respectively. 𝜆ex = 610 nm; slit 6/6 nm. Error bars represent standard deviations obtained from three independent experiments.

after Cy-Mu-7 injection. Adriamycin induced nephropathy was
reported to be an experimental analogue of human minimal lesion nephrotic syndrome.[33,34] BALB/c mice developed nephrotic
syndrome in the ﬁrst two weeks and aggravated in the later period after IV administration of 10 mg kg−1 Adriamycin.[35] We
collected daily urine samples of Adriamycin injected mice and analyzed the protein concentrations with a BCA Protein Assay Kit.
As shown in Figure 4D, the protein concentration increased signiﬁcantly within 5 d after Adriamycin administration which was
consistent with the reported symptom.[35] We then injected the
complex of Cy-Mu-7-COOH-HSA intravenously to Adriamycin
injected (5 d after administration) model mice and healthy mice,
respectively. The time-dependent ﬂuorescence signal changes of
the kidneys did not display a signiﬁcant diﬀerence between the
Adriamycin and control groups (Figure S17, Supporting Information). In the ventral images, however, a distinct ﬂuorescence
signal appeared in the bladder of the Adriamycin group 90 min
after Cy-Mu-7-COOH-HSA injection (Figure 4F). The in vivo ﬂuorescence monitoring results were further conﬁrmed by the ﬂuorescence images of urine samples collected within 2 h after
Cy-Mu-7-COOH-HSA injection. Adriamycin group resulted in
stronger uric ﬂuorescence compared with the control group (Figure 4E). The corresponding ﬂuorescence images of the abdominal cavity of mice further illustrated the distribution of ﬂuorescence signals in both of the Adriamycin and control groups (Fig-
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ure 4G). In the subsequent H&E staining of kidney tissue resected from the corresponding Adriamycin administrated mice,
no signiﬁcant histological lesion was found compared with the
control group (Figure S18, Supporting Information). The present
results demonstrated that the new NIR dyes could be used as a
sensitive tool for early-stage of AKI imaging in vivo.
The IV injected Cy-Mu-7 metabolized through both kidney
and liver. Interestingly, we found that the ﬂuorescence intensity ratios of kidney-to-liver (K/L ratio) were age-dependent (Figure S19, Supporting Information). Considering that age was reported to independently predict hepatocellular death or transplantation and associated with an increased risk of death, we constructed acute liver injury mice model upon IP injection of over
dosage APAP (600 mg kg−1 , sodium carboxymethyl cellulose suspension) to evaluate the metabolic proportion modulation.[36,37]
Comparing with the control group, APAP group displayed a
twofold K/L ratio of the corresponding ﬂuorescence intensities
(Figure 5A-1, A-2,B). This result might be caused by the druginduced liver failure which decreased the clearance of exogenous
substances through the reticuloendothelial system and, thus, increased their renal clearance proportion. N-acetylcysteine (NAC)
has a signiﬁcant therapeutic eﬀect in the treatment of APAPinduced acute liver injury.[38,39] In our experiments, we tested
the dosing order induced diﬀerence in the therapeutic eﬀect of
NAC. As shown in Figure 5A-3, IP injection of 400 mg kg−1 NAC
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Figure 4. Metabolism of Cy-Mu-7 in mice upon IV injection and AKI in vivo imaging. A) The illustration of diseases prediction based on in vivo ﬂuorescence distribution. B) Time-dependent in vivo ﬂuorescence imaging of mouse IV injected with 100 μL PBS containing 160 μm Cy-Mu-7 and 10 mg mL−1
HSA and C) the corresponding average ﬂuorescence intensities of the ROI in (B). D) Analysis of protein concentration in urine by a BCA Protein Assay
Kit. 10 mg kg−1 Adriamycin (water solution, 100 μL/20 g body weight) was administrated upon IV injection. E) Fluorescence images of urine samples
collected from the 5-day-Adriamycin administrated mice and healthy mice within 2 h after Cy-Mu-7-COOH-HSA (PBS solution containing 160 μm Cy-Mu7-COOH and 10 mg mL−1 HSA, 100 μL/20 g body weight) injection, respectively. F) Time-dependent in vivo ﬂuorescence imaging of 5-day-Adriamycin
administrated and healthy mice after IV injection of 100 μL PBS solution containing 160 μm Cy-Mu-7-COOH and 10 mg mL−1 HSA. G) Ex vivo ﬂuorescence images of abdominal cavity of 5-day-Adriamycin administrated and healthy mice at 90 min after IV injection of 100 μL PBS solution containing
160 μm Cy-Mu-7-COOH and 10 mg mL−1 HSA. Error bars represent standard deviations obtained from three independent experiments. Ki, kidney; Li,
liver; Bl, bladder; Sp, spleen.
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Figure 5. Fluorescence intensity ratios of kidney-to-liver for drug induced liver injury imaging. A) Fluorescence images of kidney and liver organs harvested from mice, which were IP injected with 1. saline, 2. 24 mg APAP, 3. 16 mg NAC and 24 mg APAP 1 h after NAC injection, 4. 24 mg APAP and 16 mg
NAC 1 h after APAP injection and further IV injected with PBS solution containing 160 μm Cy-Mu-7 and 10 mg mL−1 HSA 24 h after APAP injection, 5 h
after the dye injection. B) Corresponding K/L ratios of (A). C) H&E staining of the corresponding liver tissues of (A). 6-week-old male ICR mice were
used in these experiments. Error bars represent standard deviations obtained from three independent experiments. Ki, kidney; Li, liver. Scale bar, 60 μm.

1 h before APAP administration (NAC-APAP group) did not reverse the K/L ratio compared with the APAP group. However,
NAC injected 1 h after APAP administration (APAP-NAC group)
could induce a distinct K/L ratio decrease compared with the
APAP or NAC-APAP group (Figure 5A-4,BB). The organs’ ﬂuorescence imaging results were further veriﬁed by histopathological analysis (Figure 5C and Figure S20, Supporting Information).
H&E staining of the corresponding liver tissues illustrated that
signiﬁcant tissue necrosis appeared (the red-dotted outline) in
the NAC-APAP group. Besides, distinct focal hemorrhage (green
arrow) and nuclear pyknosis (yellow arrow) could be found in
the slice. The condition was greatly improved in the APAP-NAC
group which displayed small scale inﬂammatory inﬁltrate (the
red-dotted outline) and red blood cells extravasate (green arrow).
The dosing order dependent therapeutic eﬀect diﬀerence might
be caused by the eﬃcient pharmacokinetics of NAC upon IP
administration.[38,40] The corresponding liver function decline induced renal clearance pressure exacerbation of exogenous substances might explain the undigested fact that non-alcoholic fatty
liver diseases are independently association with the increased
incidence of chronic kidney diseases.

2.4. In Vivo Transient H2 O2 Fluctuation Imaging by Cy-Mu-7
Based Nanoprobe
H2 O2 has long been recognized as an important endogenous signaling molecule that modulates physiological processes such as
stem cell growth, proliferation, and diﬀerentiation.[41,42] Since the
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Niethammer group visualized the H2 O2 production at the wound
margin of zebraﬁsh and illustrated its signaling roles to recruit
immune cells for wound regeneration based on a genetically encoded H2 O2 ﬂuorescent probe in 2009, the research on relevant
physiological processes at the small animal level has been stagnant due to the lack of eﬃcient ﬂuorescent probes with high
SNR for in vivo imaging.[43–45] Chemiluminescence-based detection system is a preferred option to realize ultra-high SNR H2 O2
imaging because of the noise-free feature.[46,47] As shown in
Figure 6, bis[3,4,6-trichloro-2-(pentyl-oxycarbonyl)phenyl]oxalate
(CPPO) reacted with H2 O2 to produce a speciﬁc active intermediate named 1,2-dioxetanedione which was further degraded spontaneously and transferred chemical energy to the nearby ﬂuorophore through CRET.[18,48] The Zhang group reported that the
energy gap between the LUMO of the 1,2-dioxetanedione and the
HOMO of the dyes should be ranged between 1.20 and 5.01 eV to
realize eﬃcient CRET.[18] Supported by our aforementioned spectral and computational results of Cy-Mu-7, we speculated that CyMu-7 as a proper acceptor might facilitate the NIR chemiluminescence H2 O2 detection to avoid the generally used ineﬃcient
multi-stage coupling of CRET and ﬂuorescence resonance energy
transfer.
Thus, we encapsulated the Cy-Mu-7 and CPPO by Pluronic F127 to construct a nanoprobe named NIR-chemiluminescencenanoprobe (NIR-Cl-NP).[18,49,50] NIR-Cl-NP displayed similar optical properties in aqueous solution with the Cy-Mu-7-HSA
system and the average diameters were ≈20 nm as determined by dynamic light scattering and transmission electron
microscopy (Figure 7A–C). To evaluate the chemiluminescence
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subcutaneously to the joints of mice hindlimbs. As shown in Figure 7I, the presence of catalase inhibited the chemiluminescence
signal signiﬁcantly after arthrocentesis. Thus, as far as we know,
NIR-Cl-NP as a robust probing system realized the in vivo visualization of transient H2 O2 ﬂuctuation at the mouse level for the
ﬁrst time.

3. Conclusion

Figure 6. Noise free H2 O2 detection. A) Illustration of NIR-Cl-NP. B) The
mechanism of the chemiluminescence H2 O2 detection. C) NIR-Cl-NP for
H2 O2 dynamic imaging in vivo.

H2 O2 detection properties of NIR-Cl-NP, we then performed
time-dependent chemiluminescence imaging experiments upon
addition of H2 O2 to a NIR-Cl-NP containing centrifuge tube at
37 °C (Figure 7D,E). The chemiluminescence intensity of the reaction system enhanced sharply within the ﬁrst 1 min and peaked
after 6 min of reaction with a 70 000-fold enhancement even under the appearance of 500 μm H2 O2 . Besides, the chemiluminescence intensities were linearly correlated with the concentrations
of H2 O2 (Figure 7F). These results demonstrated that NIR-Cl-NP
could detect H2 O2 quantiﬁcationally with ultra-high SNR chemiluminescence signal.
Supported by the in vitro spectroscopic and imaging analysis
results, we further evaluated the possibility of NIR-Cl-NP to image the dynamic of H2 O2 in mice during injury. After subcutaneous injection of NIR-Cl-NP into the joints of mice hindlimbs,
we used a disposable syringe to pierce one of the joints to induce tissue trauma. After that, time-dependent chemiluminescence imaging and ﬂuorescence imaging were immediately performed by an IVIS. Fluorescence images illustrated the distribution of NIR-Cl-NP in mice. The chemiluminescence intensities enhanced signiﬁcantly in the pierced side compared with
the control side (Figure 7G). At the same time, the H2 O2 surged
at the pierced site within 2 min and then decreased rapidly
(Figure 7H). Compared with the reported dynamic of H2 O2 at
the wound margin in zebraﬁsh, the chemiluminescence intensity decrease might be caused by the fast diﬀusion of H2 O2 in
tissues of mice.[43,51] To further verify that the chemiluminescence signals were caused by the endogenic H2 O2 , we added
2000 unit mL−1 catalase to the solution of NIR-Cl-NP and injected
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In conclusion, we successfully transformed traditional cyanine7 dyes via asymmetrical introduction of a pyridine group to obtain new cyanine dyes with activable NIR ﬂuorescence signals
and enlarged Stokes shift (≈230 nm). These improvements led
to an increased SNR when applied to in vivo imaging applications. For instance, using the present Cy-Mu-7 dyes, we were able
to achieve ultra-fast and high contrast in vivo kidney labeling in
mice, as well as the ﬂuorescence-based detection of acute kidney injury induced by nephrotoxic drugs. We found that liver failure exacerbated renal clearance of the dye, leading us to suggest
that a change in clearance pathways might underpin the association between non-alcoholic fatty liver disease and increased incidence of chronic kidney disease. To functionalize the dyes and
construct noise-free imaging tools, we encapsulated the chemiluminescence reaction moiety of H2 O2 and Cy-Mu-7 by Pluronic
F-127 to obtain nanoprobe for H2 O2 detection that operates with
ultra-high SNR. This nanoprobe allowed transient production
and ﬂuctuation of endogenous H2 O2 in a murine model for emergency trauma to be observed readily. The present study provides
a roadmap for improving the performance improvement of ﬂuorescent probes. This, in turn, might allow the development of an
increased understanding of cell processes in situ using relatively
non-perturbing, optical-based analysis methods.

4. Experimental Section
Materials: Albumin from rat serum was purchased from SigmaAldrich. Bovine serum albumin was purchased from Innochem. Albumin human was purchased from Psaitong. The 4–12% SDS-PAGE Precast
Gel, Coomassie Blue Super-Fast Staining Solution and the related materials were all purchased from Beyotime. All chemicals were purchased
from commercial suppliers and used without further puriﬁcation. All solvents were puriﬁed prior to use. Distilled water was used after passing
through a water ultra-puriﬁcation system. TLC analysis was performed using precoated silica plates. Edinburgh FS5 and Hitachi F−7000 ﬂuorescence spectrophotometer were employed to measure ﬂuorescence spectra. Edinburgh SC-30 integrating sphere was used to measure the absolute
quantum yields of the dyes. Hitachi U-3900 UV–vis spectrophotometer
was employed to measure UV–vis spectra. Shanhai Huamei Experiment
Instrument Plants provided a PO-120 quartz cuvette (10 mm). 1 H NMR
and 13 C NMR experiments were performed with a BRUKER AVANCE III
HD 600 and 151 MHz NMR spectrometer, respectively (Bruker, Billerica,
MA). Coupling constants (J values) are reported in hertz. HR-MS determinations were carried out on a Thermo Scientiﬁc Q Exactive Instrument.
The BIO-RAD Mini-PROTEAN Tetra Cell was used in the electrophoresis
experiments. The corresponding ﬂuorescent images and Coomassie blue
staining images were obtained by a BIO-RAD ChemiDoc XRS+ Imaging
System. The in vivo imaging experiments and ex vivo imaging experiments
were performed with an IVIS Lumina LT Series III system. Cell imaging experiments were performed with a ZEISS LSM-710 Confocal Fluorescence
Microscopy. The TEM image was obtained by a JEM-2100 Transmission
Electron Microscope. Zetasizer Nano ZS nanoparticle analyzer was used
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Figure 7. In vivo transient H2 O2 ﬂuctuation imaging. A) UV–vis absorption and ﬂuorescence spectra of 5 mg mL−1 NIR-Cl-NP in water. B) DLS and
C) TEM image of NIR-Cl-NP. D) Time dependent chemiluminescence responses of 5 mg mL−1 NIR-Cl-NP toward 500 μm H2 O2 and 5 mm H2 O2
in water at 37 °C. E) Corresponding chemiluminescence intensity changes of (D). F) Quantitative analysis of H2 O2 by 5 mg mL−1 NIR-Cl-NP. The
chemiluminescence intensities were obtained 6 min after H2 O2 addition at 37 °C. Inset: Corresponding chemiluminescence images obtained by an IVIS
with Cy5.5 ﬁlter. G) Synchronous ﬂuorescence imaging and chemiluminescence imaging of H2 O2 production and ﬂuctuation in mice after arthrocentesis.
5 μL 10 mg mL−1 NIR-Cl-NP was injected via hypodermic injection. H) Corresponding chemiluminescence radiance changes of (G). I) Synchronous
ﬂuorescence imaging and chemiluminescence imaging of H2 O2 in mice after arthrocentesis with or without the presence of 2000 unit/mL catalase.
𝜆ex = 610 nm; slit 6/6 nm. Error bars represent standard deviations obtained from three independent experiments.
in the DLS analysis experiments. Male 6-week-old BALB/c-nu mice were
purchased from SPF (Beijing) Biotechnology Co., Ltd. Production Permit
No.: SCXK (Beijing) 2019-0010. Male 6-week-old ICR mice were purchased
from Shanxi Jetman Biotechnology Co., Ltd. Production Permit No.: SCXK
(Shanxi) 2019-0010. This study was performed in strict accordance with
the Chinese guidelines for the care and use of laboratory animals and was
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approved by the Institutional Animal Care and Use Committee of Scientiﬁc
Research in Shanxi University (SXULL2019033).
Synthesis of the Dyes: All of the synthesis procedures and characterization data were presented in the supporting information.
Preparation of NIR-Cl-NP: The preparation of the NIR-Cl-NP was
based on the reported procedure by the Zhang group.[18]
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Preparation of Solutions of Dyes and Analytes: Stock solution of the dyes
(2 mm) was prepared in DMSO. Stock solutions of other analytes were
prepared by direct dissolution in deionized water. All chemicals used were
of analytical grade.
General Fluorescence Spectra Measurements: The detection experiments were measured in PBS (pH 7.4, 10 mm). Typically, into a 950 μL
PBS solution, 50 μL albumin solution (20 mg mL−1 ) and 5 μL dye were
added. The ﬂuorescence spectra were obtained by ﬂuorescence spectrometer 10 min after mixing.
Theoretical Calculation: The DFT and TD-DFT were employed to understand the structural and electronic properties of Cy-7 and Cy-Mu-7 in
the Gaussian 16 A code.[19] The molecular structures of Cy-7 and Cy-Mu-7
in the ground state were optimized at M06-2X/6-31G(d) level.[52] Besides,
the solvent eﬀect (in water) was included in all calculations using the polarizable continuum model (PCM). The stable structures have been veriﬁed
via frequency analysis without imaginary frequency. A localized orbital locator (LOL-𝜋) has been applied to investigate the molecular characteristic
of 𝜋 electrons using Multiwfn 3.7.[22,23] The maximum absorption wavelength of Cy-7 and Cy-Mu-7 were calculated using an empirical equation
given by Nakano.[53]
Molecular Docking: The ligand-removed crystal structure of HSA (PDB
ID: 6R7S) was taken from the Brookhaven Protein Data Bank (http://
www.rcsb.org/pdb). The AutoGrid was used to calculate Grids. The grid
spacing was 0.375 Å as default. Flexible ligand docking was performed by
AutoDock 4.2 molecular docking program using the implemented empirical free energy function and the Lamarckian Genetic Algorithm. 2000 docking runs with 2 500 000 energy evaluations were performed. The lowest
energy structures of each independent run were clustered with an RMStolerance of 2.0 Å. The output from AutoDock was rendered with PyMol
(http://www.pymol.org/).
Cell Culture and Imaging: The HeLa cells were grown in 1640 medium
supplemented with 12% FBS and 1% antibiotics at 37 °C in humidiﬁed
environment of 5% CO2 . Cells were plated on a 6-well plate with slides
and allowed to adhere for 24 h. Before the experiments, cells were washed
with PBS 3 times. The ﬂuorescence images were obtained by a ZEISS LSM710 Confocal Fluorescence Microscopy.
Ex vivo Chemiluminescence Imaging of Hydrogen Peroxide: 5 mg mL−1
NIR-Cl-NP was added in the centrifuge tube and stock solution of hydrogen peroxide was then added with a ﬁnal concentration of 500 μm or 5 mm.
The corresponding chemiluminescence intensities were monitored by an
IVIS. Emission ﬁlter: Cy5.5.
In Vivo Fluorescence Imaging: For a general real-time ﬂuorescence
imaging, 6-week-old BALB/c-nu mice without treatment were imaged by
an IVIS Lumina LT Series III system as the blank control. After IV injection of a PBS solution containing 160 μm Cy-Mu-7 and 10 mg mL−1 HSA,
the mice were imaged under the system upon isoﬂurane anesthesia immediately. For the Adriamycin induced AKI model imaging, 10 mg kg−1
Adriamycin (a water solution, 100 μL/20 g body weight) was injected intravenously into mice. 5 d after Adriamycin injection, the mice were injected
with a PBS solution containing 160 μm Cy-Mu-7 dyes and 10 mg mL−1
HSA intravenously and imaged under the system upon isoﬂurane anesthesia immediately. Excitation ﬁlter: 605 nm; Emission ﬁlter: Cy5.5.
Protein Concentration Analysis in Urine: Healthy mice and 10 mg kg−1
Adriamycin injected 6-week-old BALB/c-nu mice were domesticated and
spontaneously voided urine samples were collected every day. 10 μL of
the urine samples were added to the BCA Protein Assay Kit and analyzed
according to the standard method.
Ex Vivo Mouse Imaging: 6-week-old male ICR mice were injected intraperitoneally with saline as the control group, 24 mg APAP containing
0.5% CMC suspension as the APAP group, 16 mg NAC containing saline
and further 24 mg APAP containing 0.5% CMC suspension 1 h after NAC
injected as the NAC-APAP group, 24 mg APAP containing 0.5% CMC suspension and further 16 mg NAC containing saline 1 h after APAP injected
as the APAP-NAC group, respectively. PBS solution containing 160 μm CyMu-7 and 10 mg mL−1 HSA were IV injected 24 h after APAP injection and
the kidney and liver organs were harvest 5 h after dye injection and imaged
immediately.
Detailed synthesis of dyes was presented in Supporting Information.
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